| Ranibizumab (Lucentis) for Polypoidal Choroidal Vasculopathy (NCT00837330) | Southeast Retina Center, Georgia | 2006-05-01 |
| Home Care Medication Management Program for the Frail Elderly (NCT01321853) | Arizona State University | 2006-05-01 |
| Temsirolimus, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme (NCT00316849) | National Cancer Institute (NCI) | 2006-05-01 |
| Vorinostat, Cytarabine, and Etoposide in Treating Patients With Relapsed and/or Refractory Acute Leukemia or Myelodysplastic Syndromes or Myeloproliferative Disorders (NCT00357305) | National Cancer Institute (NCI) | 2006-05-01 |
| Effect of Samarium on the Relief of Pain Due to Vertebral Metastases (NCT00374751) | New York Presbyterian Brooklyn Methodist Hospital | 2006-05-01 |
| Bioequivalence Study of Carbidopa/Levodopa/Entacapone Combination vs. Carbidopa/Levodopa Combination Plus Entacapone in Healthy Volunteers (NCT00415740) | Novartis | 2006-05-01 |
| Pulmonary Hypertension: Assessment of Cell Therapy (NCT00469027) | Northern Therapeutics | 2006-05-01 |
| Bioequivalence Study of Naproxen Sodium 550 mg Tablets Under Fed Conditions (NCT01052792) | Dr. Reddy's Laboratories Limited | 2006-05-01 |
| Affect Management Group for Adult Survivors of Childhood Trauma (NCT00383006) | University of Zurich | 2006-05-01 |
| Sirolimus and Cyclosporine for Treatment-Resistant Aplastic Anemia (NCT00319878) | Office of Rare Diseases (ORD) | 2006-05-01 |
| PXD101 and 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Metastatic or Unresectable Solid Tumors or Lymphoma (NCT00354185) | National Cancer Institute (NCI) | 2006-05-01 |
| A Phase I/II Study of CP-4055 in Patients With Refractory/Relapsed Hematologic Malignancies (NCT00405743) | Clavis Pharma | 2006-05-01 |
| Cidofovir in Renal Transplant Recipients With BKVN (NCT00138424) | National Institute of Allergy and Infectious Diseases (NIAID) | 2006-05-01 |
| Immunoscintigraphy Using Radiolabeled Monoclonal Antibody in Finding Tumor Cells in Patients With Colorectal Cancer (NCT00647153) | City of Hope Medical Center | 2006-05-01 |
| YSPSL for Prevention of Delayed Graft Function Part B (NCT00298168) | Y's Therapeutics, Inc. | 2006-05-01 |
| Intra-arterial Chemotherapy(Chemosurgery) for Retinoblastoma (NCT00901238) | Weill Medical College of Cornell University | 2006-05-01 |
| Xenogeneic HER2/Neu DNA Immunization for Patients With Metastatic and High Risk Breast Cancer: A Phase I Study to Assess Safety and Immunogenicity (NCT00393783) | Memorial Sloan Kettering Cancer Center | 2006-05-01 |
| Phase I BP Interferon (IFN) Beta-004 (NCT02517788) | Centre Hospitalier Universitaire Vaudois | 2006-05-01 |
| A Phase I Dose-Escalation Study of BMS-641988 in Patients With Castration-Resistant Prostate Cancer (NCT00326586) | Bristol-Myers Squibb | 2006-05-01 |
| Dual-Plane Breast Augmentation: Axillary Approach With Assistant of Endoscope (NCT00505557) | Chinese Academy of Sciences | 2006-05-01 |
| Study Evaluating the Effects of Multiple Oral Doses of ERB-041 on Cardiac Repolarization in Healthy Subjects (NCT00316459) | Wyeth is now a wholly owned subsidiary of Pfizer | 2006-05-01 |
| MR Guided Focused Ultrasound Surgery of Metastatic Bone Tumors (NCT00350233) | InSightec | 2006-05-01 |
| Wide-Bandwidth Open Canal Hearing Aid For Better Multitalker Speech Understanding (NCT00582946) | EarLens Corporation | 2006-05-01 |
| Role of Minocycline in First Episode Psychosis (NCT00916461) | Stanley Medical Research Institute | 2006-05-01 |
| Phase 1 Clinical Trial of NPI-0052 in Patients With Advanced Solid Tumor Malignancies or Refractory Lymphoma (NCT00396864) | Celgene | 2006-05-01 |
| Target Dosing of Docetaxel Through Pharmacokinetic/Pharmacodynamic Optimisation of the First Chemotherapeutic Cycle (NCT00703378) | National University Hospital, Singapore | 2006-05-01 |
| Evaluation Of Linezolid Pk Profile In Burns Patients (NCT00255996) | Pfizer | 2006-05-01 |
| Iron Substitution After Total Knee Arthroplasty (NCT01611181) | Northern Orthopaedic Division, Denmark | 2006-05-01 |
| Monoclonal Antibody (mAb) 216 With Chemotherapy in Adult Relapsed or Refractory B-Lineage Acute Lymphoblastic Leukemia (NCT00313079) | Steven E. Coutre | 2006-05-01 |
| Vaccine Therapy in Treating Patients With Malignant Glioma (NCT00612001) | Jonsson Comprehensive Cancer Center | 2006-05-01 |
| Pivotal Study of the Al-Sense Study Protocol (NCT00604838) | Western Galilee Hospital-Nahariya | 2006-05-01 |
| Post-transplant Autologous Cytokine-induced Killer (CIK) Cells for Treatment of High Risk Hematologic Malignancies (NCT00477035) | Sally Arai | 2006-05-01 |
| Almorexant in Primary Insomnia (NCT00640848) | Midnight Pharma, LLC | 2006-05-01 |
| Pilot Study to Assess the Efficacy and Safety of the Lubo Cervical Collar (NCT00355173) | Hadassah Medical Organization | 2006-05-01 |
| Safety Study of Radiotherapy and Concurrent Erlotinib (Tarceva®) for Brain Metastases From a Non-Small Cell Lung Cancer (NCT00536861) | Amsterdam UMC, location VUmc | 2006-05-01 |
| Acute Safety, Tolerability, Feasibility and Pharmacokinetics of Intrath. Administered ATI355 in Patients With Acute SCI (NCT00406016) | Novartis | 2006-05-01 |
| Study of Autologous Conditioned Serum After Anterior Cruciate Ligament Reconstructive Surgery (NCT01037738) | University of Zagreb | 2006-05-01 |
| Weekly Subcutaneous Alemtuzumab and Rituximab for Relapsed CLL (NCT00330252) | Dana-Farber Cancer Institute | 2006-05-01 |
| Evaluation of Deep Transcranial Magnetic Stimulation (TMS) H-Coil in the Treatment of Major Depression (NCT00445237) | Shalvata Mental Health Center | 2006-05-01 |
| Enhancing Motivation To Quit Smoking In Smokers With Serious Mental Illness (NCT00500695) | Rutgers, The State University of New Jersey | 2006-05-01 |
| Alloreactive NK Cells for Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) (NCT00402558) | M.D. Anderson Cancer Center | 2006-05-01 |
| Safety of LBH589 Alone and in Combination With Intravenous Docetaxel and Prednisone (NCT00419536) | Novartis Pharmaceuticals | 2006-05-01 |
| Safety of and Immune Response to an HIV-1 Vaccine (VRC-HIVDNA016-00-VP) and a Vaccine Booster (VRC-HIVADV014-00-VP) in HIV Uninfected East African Adults (NCT00123968) | National Institute of Allergy and Infectious Diseases (NIAID) | 2006-05-01 |
| Study Evaluating the Safety of Lecozotan SR in Healthy Young and Elderly Subjects (NCT00366483) | Wyeth is now a wholly owned subsidiary of Pfizer | 2006-05-01 |
| Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SAM-531 in Healthy Subjects (NCT00479700) | Wyeth is now a wholly owned subsidiary of Pfizer | 2006-05-01 |
| Interdisciplinary Falls Prevention for Seniors (NCT00463658) | Hamilton Health Sciences Corporation | 2006-05-01 |
| Safety of LBH589 Alone and in Combination With IV Docetaxel and Prednisone (NCT00493766) | Novartis Pharmaceuticals | 2006-05-01 |
| Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Rising Doses of BI 1356 BS in Healthy Male Volunteers (NCT02183298) | Boehringer Ingelheim | 2006-05-01 |
| Docetaxel With or Without Phenoxodiol in Treating Patients With Recurrent Advanced Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cavity Cancer (NCT00303888) | Yale University | 2006-05-01 |
| Study of Bevacizumab in Combination With 5-FU, Oxaliplatin and External Beam Radiation Followed by Gemcitabine and Bevacizumab for Locally Advanced Pancreatic Cancer (NCT00307723) | Massachusetts General Hospital | 2006-05-01 |
| Multiple-Dose, Dose-Escalation Safety, Pharmacodynamics, and Pharmacokinetics Study of Imprime PGG™ Injection (NCT00542464) | HiberCell, Inc. | 2006-05-01 |
| Effect of Liraglutide on Gastrointestinal Absorption of Several Drugs and Potential Influence of Liraglutide on Intragastric pH (NCT01518166) | Novo Nordisk A/S | 2006-05-01 |
| FTS Study in Patients With Advanced Hematologic Malignancies (NCT00867230) | M.D. Anderson Cancer Center | 2006-05-01 |
| Study to Evaluate the Safety and Pharmacokinetics of SPI-1005 (NCT01452607) | Sound Pharmaceuticals, Incorporated | 2006-05-01 |
| Pharmacokinetics, Safety and Pharmacodynamics After Multiple Oral Doses of Dabigatran Etexilate Capsule in Healthy Japanese and Caucasian Male Subjects (NCT02171468) | Boehringer Ingelheim | 2006-05-01 |
| A Study of MORAb-009 in Subjects With Pancreatic Cancer, Mesothelioma, or Certain Types of Ovarian or Lung Cancer (NCT00325494) | Morphotek | 2006-05-01 |
| Bioequivalence of Two Insulatard® Formulations in Healthy Subjects (NCT01486901) | Novo Nordisk A/S | 2006-05-01 |
| Bioequivalence of Two Mixtard® 30 Formulations in Healthy Subjects (NCT01486888) | Novo Nordisk A/S | 2006-05-01 |
| Dose Escalation Study of Pharmacokinetics, Safety and Tolerability After Single Dose Administration of BILR 355 (SDS) Plus Low-dose Ritonavir in Healthy Volunteers (NCT02253927) | Boehringer Ingelheim | 2006-05-01 |
| Endothelin Receptor Antagonism in Proteinuric Nephropathy (NCT00722215) | University of Edinburgh | 2006-05-01 |
| Docetaxel/Pemetrexed as 1st Line Treatment in Patients With Non Small Cell Lung Cancer (NSCLC) (NCT00684099) | Hellenic Oncology Research Group | 2006-05-01 |
| A Phase I Open Label Study of E7974 Administered on a Day 1 of 21-Day Cycle In Patients With Advanced Solid Tumors (NCT00165802) | Eisai Inc. | 2006-05-01 |
| A Randomized, Controlled, Clinical Trial of Biofeedback and Anal Injections as First Treatment of Fecal Incontinence (NCT00303030) | University Hospital of North Norway | 2006-05-01 |
| Safety and Efficacy Study of TNX-650 to Treat Refractory Hodgkin's Lymphoma (NCT00441818) | Tanox | 2006-05-01 |
| TNF-Bound Colloidal Gold in Treating Patients With Advanced Solid Tumors (NCT00356980) | National Institutes of Health Clinical Center (CC) | 2006-05-01 |
| Use of the Atkins Diet for Children With Sturge Weber Syndrome (NCT00639730) | Johns Hopkins University | 2006-05-01 |
| Spinal Cord Stimulation Efficacy Measures (NCT00351208) | New York Neurosurgery & Neuroscience Associates, PLLC | 2006-05-01 |
| A Study of the Bioequivalence of 70-mg Alendronate and 70-mg Alendronate in Combination With 5600 IU Vitamin D (MK0217A-253) (NCT00803790) | Organon and Co | 2006-05-01 |
| Bioequivalence Study of Naproxen Sodium 550 mg Tablets Under Fasting Condition (NCT01052129) | Dr. Reddy's Laboratories Limited | 2006-05-01 |
| RTA 402 in Patients With Advanced Solid Tumors or Lymphoid Malignancies (NCT00529438) | Biogen | 2006-04-30 |
| Pazopanib (VOTRIENT) Plus Paclitaxel (TAXOL), Pazopanib Plus Paclitaxel (TAXOL) Plus Carboplatin (PARAPLATIN), and Pazopanib Plus Paclitaxel (TAXOL) Plus Lapatinib (TYKERB) (NCT00388076) | GlaxoSmithKline | 2006-04-28 |
| Trial of PTK787/ZK 222584 Plus Paclitaxel (NCT00358163) | Dana-Farber Cancer Institute | 2006-04-26 |
| AZD0530 and Gemcitabine in Locally Advanced/Metastatic Pancreatic Cancer That Cannot Be Removed By Surgery (NCT00265876) | NCIC Clinical Trials Group | 2006-04-26 |
| Effect of BIA 6-512 at Steady-state on the Levodopa Pharmacokinetics (NCT03094156) | Bial - Portela C S.A. | 2006-04-26 |
| Phase I Study of Vaccination Schedule of Experimental HIV Vaccines (NCT00321061) | National Institute of Allergy and Infectious Diseases (NIAID) | 2006-04-25 |
| Radiation Therapy and Docetaxel in Treating Patients Who Are Undergoing Surgery for Localized Prostate Cancer (NCT00321698) | OHSU Knight Cancer Institute | 2006-04-21 |
| A Study Of Oral PF-02341066, A C-Met/Hepatocyte Growth Factor Tyrosine Kinase Inhibitor, In Patients With Advanced Cancer (NCT00585195) | Pfizer | 2006-04-19 |
| Study Of Eltrombopag in Healthy Subjects and Volunteers With Mild, Moderate or Severe Hepatic Impairment (NCT00359463) | GlaxoSmithKline | 2006-04-18 |
| Antagonist-Elicited Cannabis Withdrawal (NCT01041170) | National Institute on Drug Abuse (NIDA) | 2006-04-16 |
| VELCADE®-BEAM and Autologous Hematopoietic Stem Cell Transplantation for Non-Hodgkin's Lymphoma, or Mantle Cell Lymphoma (NCT00571493) | University of Nebraska | 2006-04-14 |
| Non-Exercise Activity Thermogenesis (NEAT) in Children (NCT00315172) | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | 2006-04-13 |
| Exploratory Clinical Study to Evaluate Sodium Oxybate (Xyrem) on Potential Endocrine Changes (NCT00345800) | UCB Pharma SA | 2006-04-10 |
| Nesiritide Use Following Cardiac Surgery in Infants (NCT00281671) | Boston Children's Hospital | 2006-04-08 |
| A Phase I/II Trial of VELCADE & Gemcitabine for Patients With Relapsed or Refractory Aggressive B- and T-cell Non-Hodgkin's Lymphoma (NCT00290706) | Northwestern University | 2006-04-07 |
| GW572016 Combined With Trastuzumab For The Treatment Of Previously Trastuzumab-Treated Breast Cancer (NCT00371488) | GlaxoSmithKline | 2006-04-06 |
| A Study of the Relationship Between Disulfiram and Cocaine Self-administration. (NCT00729300) | Baylor College of Medicine | 2006-04-01 |
| A Study of Anginera In Patients Undergoing Coronary Artery Bypass Graft (CABG) Surgery (NCT00364390) | Theregen, Inc. | 2006-04-01 |
| Sorafenib and Temsirolimus in Treating Patients With Metastatic, Recurrent, or Unresectable Melanoma (NCT00349206) | National Cancer Institute (NCI) | 2006-04-01 |
| Bioequivalence of NovoSeven® and a NovoSeven® Formulation Stable at Room Temperature in Healthy Male Subjects (NCT01561417) | Novo Nordisk A/S | 2006-04-01 |
| Use of TRC Autologous Bone Marrow Cells in Posterolateral Lumbar Spine Fusion (NCT00797550) | Vericel Corporation | 2006-04-01 |
| Investigation of a Behavioral Substitute for Sunbathing (NCT00403377) | University of Massachusetts, Worcester | 2006-04-01 |
| 30-Day Trial of Oral Valtrex or Valtrex Plus Aspirin on Shedding of HSV DNA in Tears and Saliva of Volunteers (NCT00587496) | National Eye Institute (NEI) | 2006-04-01 |
| Bioequivalence of Two Different Drug Product Batches of Dabigatran Etexilate Following Oral Administration in Healthy Male and Female Volunteers (NCT02171013) | Boehringer Ingelheim | 2006-04-01 |
| Concurrent Radiotherapy With Weekly Topotecan for Primary Treatment of Inoperable Localized Non-small Cell Lung Cancer (NCT00322751) | University of New Mexico | 2006-04-01 |
| A Phase 1 Trial of Extended MLN8054 Dosing in Patients With Advanced Malignancies (NCT00652158) | Millennium Pharmaceuticals, Inc. | 2006-04-01 |
| Panitumumab Chemoradiotherapy Chemotherapy for Squamous Cancer of the Head and Neck (NCT00513383) | Massachusetts General Hospital | 2006-04-01 |
| St. Jude Open Label H5 Trial (NCT00311675) | National Institute of Allergy and Infectious Diseases (NIAID) | 2006-04-01 |
| Understanding Dexmedetomidine in Neonates After Open Heart Surgery (NCT00576381) | Athena Zuppa | 2006-04-01 |
| Safety of Autologous Stem Cell Treatment for Traumatic Brain Injury in Children (NCT00254722) | The University of Texas Health Science Center, Houston | 2006-04-01 |
| Study of PHA-848125AC in Adult Patients With Advanced/Metastatic Solid Tumors (NCT01300468) | Nerviano Medical Sciences | 2006-04-01 |